- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Patent holdings for IPC class A61K 31/165
Total number of patents in this class: 3612
10-year publication summary
|
239
|
277
|
273
|
289
|
317
|
303
|
280
|
218
|
222
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19517 |
49 |
| Novartis AG | 11254 |
44 |
| Les Laboratoires Servier | 597 |
41 |
| Newron Pharmaceuticals S.p.A. | 65 |
40 |
| Allergan, Inc. | 2438 |
23 |
| LTS Lohmann Therapie-Systeme AG | 705 |
23 |
| The General Hospital Corporation | 4650 |
19 |
| Murray and Poole Enterprises Limited | 23 |
19 |
| Axsome Malta Ltd. | 69 |
18 |
| President and Fellows of Harvard College | 5913 |
17 |
| Indiana University Research and Technology Corporation | 800 |
17 |
| Vanda Pharmaceuticals, Inc. | 356 |
16 |
| Bristol-myers Squibb Company | 4863 |
15 |
| Board of Regents, The University of Texas System | 5619 |
15 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
15 |
| GW Research Limited | 342 |
15 |
| BIAL - Portela & CA, S.A. | 237 |
14 |
| Children's Medical Center Corporation | 1826 |
14 |
| Novartis Pharma GmbH | 207 |
14 |
| The Trustees of the University of Pennsylvania | 4260 |
13 |
| Other owners | 3171 |